ClinicalTrials.gg
CompletedNCT06841432Updated Feb 24, 2025

Coblation Versus Suction Diathermy in Pediatric Adenoidectomy

An interventional study of adenoidectomy using coblatioion and adenoidectomy by Suction diathermy in Adenoid Hypertrophy, Adenoidectomy and Coblation Adenoidectomy, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-02-24.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jul 2024, registered Feb 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
245
Allocation
Randomized
Ages
2 Years to 18 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare two surgical procedures in endoscopic adenoidectomy including Coblation and Suction diathermy

. The main questions it aims to answer are: Does the Coblation device have less time, less pain, less postoperative crustation and bad odor, less intraoperative bleeding, and less recurrence?

Participants will:

will undergo both procedures every day for 6 months Visit the clinic once every 2 weeks for checkups and tests Keep a diary of their symptoms

02

Conditions studied

  • Adenoid Hypertrophy
  • Adenoidectomy
  • Coblation Adenoidectomy
  • Suction Daithermy

Keywords

  • Endoscopic
  • Adenoidectomy
  • adenoid hypertrophy
  • Pediatric
  • Suction Diathermy
  • Coblation
03

In context

Lead sponsor

Al-Azhar University is the lead sponsor of 525 studies on the registry; 171 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all patients aged 2 to 18 years
  • patients who had isolated adenoid hypertrophy
  • patients' hemoglobin levels above 10 mg/dl

Exclusion criteria

Exclusion Criteria:

  • those with recent upper respiratory tract infections, evidence of bleeding disorders, serous otitis media, chronic tonsillitis
  • those advised against undergoing adenoidectomy after consulting a phoniatrist
  • patients with atrophic rhinitis those with nasal obstruction caused by other nasal or paranasal conditions such as inferior turbinate hypertrophy, Choanal atresia, deviated nasal septum, antrochoanal polyps, and other causes of nasal obstruction in children.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
245 participants (actual)

Study arms

  • Active comparator
    patients who underwent the adenoidectomy using suction diathermy

    One hundred and five patients underwent a suction diathermy adenoidectomy procedure. The soft palate was gently retracted using two suction catheters, allowing a 70-degree angled endoscope (Storz, Germany) placed in the oropharynx to provide a clear view of the adenoidal tissue and surrounding structures in the nasopharynx. Using a malleable size 10 or 12 French hand-switching suction coagulator, the adenoidal tissue was carefully ablated, starting from the uppermost part. The procedure was completed when the posterior choanae were clearly visible, and the nasopharynx had a smooth, unobstructed appearance. Great care was taken to avoid injuring the Eustachian tube orifice, posterior septum, choanae, inferior turbinate, palate, and posterior pharyngeal wall. Continuous irrigation with saline, either through the mouth or the nose, helped minimize any thermal damage caused by the diathermy machine.

    Procedure: adenoidectomy by Suction diathermy

  • Experimental
    patients who underwent the adenoidectomy using coblation

    One hundred and five patients underwent a Coblation-assisted adenoidectomy procedure. The child was positioned in Rose's position, which helped retract the soft palate and improve visibility of the nasopharynx. Two soft rubber catheters were inserted into the patient's mouth, with the distal and proximal ends crossed externally and secured with a clamp. The COBLATOR™ II surgery system Model EC8000-01 was used, with a power setting of nine for ablation and five for coagulation. Under general anesthesia, the adenoidectomy was performed using either a 4 mm, 70-degree angled endoscope inserted orally or a zero-degree endoscope inserted through the nose, providing effective visualization of the nasopharynx. After the procedure, hemostasis was achieved by using a combination of the coagulation and ablation modes.

    Procedure: adenoidectomy using coblatioion

Interventions

  • Procedureadenoidectomy using coblatioion

    One hundred and five patients underwent a Coblation-assisted adenoidectomy procedure. The child was positioned in Rose's position, which helped retract the soft palate and improve visibility of the nasopharynx. Two soft rubber catheters were inserted into the patient's mouth, with the distal and proximal ends crossed externally and secured with a clamp. The COBLATOR™ II surgery system Model EC8000-01 was used, with a power setting of nine for ablation and five for coagulation. Under general anesthesia, the adenoidectomy was performed using either a 4 mm, 70-degree angled endoscope inserted orally or a zero-degree endoscope inserted through the nose, providing effective visualization of the nasopharynx. After the procedure, hemostasis was achieved by using a combination of the coagulation and ablation modes.

  • Procedureadenoidectomy by Suction diathermy

    One hundred and five patients underwent a suction diathermy adenoidectomy procedure. The soft palate was gently retracted using two suction catheters, allowing a 70-degree angled endoscope (Storz, Germany) placed in the oropharynx to provide a clear view of the adenoidal tissue and surrounding structures in the nasopharynx. Using a malleable size 10 or 12 French hand-switching suction coagulator, the adenoidal tissue was carefully ablated, starting from the uppermost part. The procedure was completed when the posterior choanae were clearly visible, and the nasopharynx had a smooth, unobstructed appearance. Great care was taken to avoid injuring the Eustachian tube orifice, posterior septum, choanae, inferior turbinate, palate, and posterior pharyngeal wall. Continuous irrigation with saline, either through the mouth or the nose, helped minimize any thermal damage caused by the diathermy machine.

06

What researchers measure

Primary outcomes

  1. Operative duration

    The procedure, from the initial insertion of the Bowel-Davis mouth gag to the complete removal of the adenoid and the gag, was timed in minutes.

    Time frame: During the procedure

  2. Intraopertive blood loss

    Boezaart surgical field grading scale was used to evaluate the intraoperative bleeding

    Time frame: during the procedures

  3. Postopertaive Pain

    The Wong-Baker Pain Scale consists of 6 faces depicting different levels of pain. Face 1 represents no pain, Face 2 indicates a little bit of hurt, Face 3 indicates a little more hurt, Face 4 indicates even more hurt, Face 5 indicates a whole lot of hurt, and Face 6 indicates the worst possible hurt, with pain scores ranging from 0 to 10. Both the children and their parents were informed about the purpose of the questionnaires and how to fill them out before the surgery

    Time frame: Patients reported their pain levels every day before taking any pain medication during the 7 days after their surgery

Secondary outcomes

  1. Development of bad breath

    frequency of Children who presented with bad breath

    Time frame: from the end of operation till 2 weeks post operation

  2. recovery time

    time which was talken for the patients to resume their normal social routines

    Time frame: three months post opertaive

  3. secondary bleeding

    frequency of Children who presented with bleeding that occurred after 24 hrs of operation

    Time frame: up to one month surgery

  4. Pre- and post-adenoid size grading

    The Parikh grading system (1-4) is used to assess the extent of adenoid tissue contact with surrounding structures: Grade 1 - adenoid tissue not in contact, Grade 2 - adenoid tissue in contact with Eustachian tube cushions, Grade 3 - adenoid tissue in contact with vomer, Grade 4 - adenoid tissue in contact with soft palate

    Time frame: preintervention (one day before opertaion ) and postintervention (up to three months)

07

Study locations

1 site
  • Alazhar university Hopital in Assiut
    Asyut, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2024 to primary completion in Jan 2025, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2025
First posted
Feb 24, 2025
StartActual
Jul 1, 2024
Primary completionActual
Jan 1, 2025
CompletionActual
Jan 1, 2025
Last update
Feb 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06841432
Responsible party
Ahmed Nabil Selim (Resident doctor of otorhinolanrgology at alazhar univeristy hopsital in assiut, Al-Azhar University) — Principal investigator
First posted
Feb 24, 2025
Start date
Jul 1, 2024
Primary completion
Jan 1, 2025
Completion
Jan 1, 2025
Last update
Feb 24, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion